These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8843494)

  • 1. Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial.
    Barak Y; Levine J; Glasman A; Elizur A; Belmaker RH
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):729-35. PubMed ID: 8843494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trials of inositol in psychiatry.
    Levine J
    Eur Neuropsychopharmacol; 1997 May; 7(2):147-55. PubMed ID: 9169302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.
    Devanand DP; Marder K; Michaels KS; Sackeim HA; Bell K; Sullivan MA; Cooper TB; Pelton GH; Mayeux R
    Am J Psychiatry; 1998 Nov; 155(11):1512-20. PubMed ID: 9812111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.
    Krishnan KR; Charles HC; Doraiswamy PM; Mintzer J; Weisler R; Yu X; Perdomo C; Ieni JR; Rogers S
    Am J Psychiatry; 2003 Nov; 160(11):2003-11. PubMed ID: 14594748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial.
    Wolters EC; Riekkinen P; Lowenthal A; Van der Plaats JJ; Zwart JM; Sennef C
    Neurology; 1990 Jul; 40(7):1099-101. PubMed ID: 2192301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.
    Petracca G; Tesón A; Chemerinski E; Leiguarda R; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):270-5. PubMed ID: 8854297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.
    Florian H; Meier A; Gauthier S; Lipschitz S; Lin Y; Tang Q; Othman AA; Robieson WZ; Gault LM
    J Alzheimers Dis; 2016; 51(4):1237-47. PubMed ID: 26967214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, controlled trial of inositol treatment of depression.
    Levine J; Barak Y; Gonzalves M; Szor H; Elizur A; Kofman O; Belmaker RH
    Am J Psychiatry; 1995 May; 152(5):792-4. PubMed ID: 7726322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
    Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
    Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
    Small G; Erkinjuntti T; Kurz A; Lilienfeld S
    CNS Drugs; 2003; 17(12):905-14. PubMed ID: 12962529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.
    Benjamin J; Levine J; Fux M; Aviv A; Levy D; Belmaker RH
    Am J Psychiatry; 1995 Jul; 152(7):1084-6. PubMed ID: 7793450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimer's disease.
    Schneider LS; Olin JT; Pawluczyk S
    Am J Psychiatry; 1993 Feb; 150(2):321-3. PubMed ID: 8422085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol treatment of autism.
    Levine J; Aviram A; Holan A; Ring A; Barak Y; Belmaker RH
    J Neural Transm (Vienna); 1997; 104(2-3):307-10. PubMed ID: 9203092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease.
    Rockwood K; Beattie BL; Eastwood MR; Feldman H; Mohr E; Pryse-Phillips W; Gauthier S
    Can J Neurol Sci; 1997 May; 24(2):140-5. PubMed ID: 9164692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease.
    Jenike MA; Albert MS; Heller H; LoCastro S; Gunther J
    J Clin Psychiatry; 1986 May; 47(5):249-51. PubMed ID: 3700343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-1 treatment of Alzheimer's disease. A pilot study of safety and efficacy.
    Ala T; Romero S; Knight F; Feldt K; Frey WH
    Arch Neurol; 1990 Oct; 47(10):1126-30. PubMed ID: 2222246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ; Pina MA; Fayed N; Díaz M
    CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.